Flight to Safety with Greek Crisis: Some Biotech Winners-SQNM,REGN
Europe debt woes, riots in Greece and a 3% CPI increase for a 12 month period spooked investors. All sectors sold off today with major indices down: NASDAQ off 1.77%,Dow off 1.5%,S&P off 1.7%. Energy, materials, technology and financials were weakest, and all down YTD. The QQQ was down 1.9%...
Relief Rally Boosts Biotechs: BIIB,EXEL,REGN
The market rallied today with the NASDAQ up 1.48 % and the S&P up 1.26%. The leading sectors today were capital goods , materials and energy. Biotechs overall were up only 0.8% but were much better even though our mid-cap index was up only 0.49%. Within the Rayno Life Science Portfolio big...
Post-ASCO Scoreboard Part 2
Following up on the previous post we can review selected small and mid-stocks participating in the ASCO Conference look at performance over 3 months from March 14 to June 13 including a 7% correction in the market overall. Most biotech stocks peaked in Q2 2011. See previous post for ASCO news...
ASCO Winners Part 1: ARIA,ECYT,INCY
Despite an ASCO "sell on the news" and a severe Q2 correction some mid and small cap cancer related stocks are still up although off their highs. See commentary and news from earlier posts. More on these and others...
Nasty Day, Nasty Month, Nasty News: Cliches Rule
All major indices and sectors sold off today making it 7 bad days out of 8 and a 6.37% correction in the S&P 500 over 30 days. The NASDAQ is now down 7.94% since May 11. Remember "sell in May and go away" ? Things were not much better in biotech-land with the IBB down 5% over one month....